Home > Press > Evolved Machines Enters Into License Agreement with Nanosys and Launches Development of DNA-activated Carbon Nanotube Transistor Sensors
Abstract:
Evolved Machines, Inc. and Nanosys Inc. today announced that Evolved Machines has entered into a sublicense agreement with Nanosys for a portfolio of patents and patent applications related to the use of nanotubes and nanowires for artificial olfaction and chemical sensing.
The core intellectual property involves a wide range of applications in nanotechnology, nanomaterials and the use of nanotube and nanowire-based field effect transistors (FET's) as biosensors. Nanosys owns an extensive portfolio of IP around multiple aspects of nanotechnology including basic nanowire compositions, nanowire synthesis and the use of nanowires and other nanostructures for many applications.
Under terms of the agreement, Evolved Machines has secured or has obtained options to secure a variety of exclusive, worldwide rights among which are the use of DNA-functionalized nanowire or nanotube-based sensor arrays for the detection and/or identification of an analyte or analytes in the gas and/or liquid phase.
Evolved Machines, in partnership with its affiliate iSense, LLC, is developing nanotube-based field effect transistors (FETS) functionalized by DNA as highly sensitive sensors across a very wide range of targets. "The DNA sequence-dependent nature of binding affinity for these devices enables highly diverse analyte discrimination, while the nanotube transistor imparts great sensitivity. Further, this class of sensor is completely reversible across a wide range of analytes, allowing repeated use and enabling the first devices capable of remote autonomous multi-analyte sensing," according to Dr. Paul A. Rhodes, Evolved Machines CEO.
Working in partnership with its affiliate, iSense, Evolved Machines is developing a wide range of immediate high-value applications ranging from airport, port and transit screening, to first responder domestic and military hand-held sets, to medical diagnosis, to autonomous 24/7 monitoring of the water supply and of containers on-board ship.
####
About Evolved Machines, Inc.
Evolved Machines, Inc. develops technology for sensory systems based on highly neural sensory signal processing, reverse-engineering circuitry in the brain to enable a new class of self-wiring devices that perform in the complexities of real-world environments, for both artificial olfaction and visual object recognition.
About Nanosys, Inc.
Nanosys, Inc. is a leader in the development of nanotechnology enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with over 600 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products for life sciences, computing, optoelectronics, renewable energy, and defense.
Additional information on Nanosys can be found at www.nanosysinc.com.
About iSense, LLC
iSense, LLC manufactures broad spectrum chemical sensing devices enabling rapid identification across thousands of analytes. These devices incorporate Evolved Machines' intelligent neural pattern recognitions algorithms to enable performance under real-world conditions. Additional information on iSense can be found at www.isensesytems.com.
For more information, please click here
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Sensors
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||